REG - AstraZeneca PLC - Annual Financial Report <Origin Href="QuoteRef">AZN.L</Origin> - Part 18
- Part 18: For the preceding part double click ID:nRSH4027Rq
state and federally operated health insurance exchanges. In general,
patients enrolled in the exchanges are subject to higher cost sharing
obligations and may not have as robust access to prescription drugs as
compared to patients enrolled in Medicare Part D or commercial plans.
Based, in part, on the impact of ACA to other healthcare sectors, there
is ongoing scrutiny of the US pharmaceutical industry that could result
in further government intervention and financial constraint. Many
stakeholders, including some in Congress and others in the broader
healthcare system, such as health plans, have dramatically increased
their criticism over the value of medicines in the US and have placed a
stronger emphasis on innovative therapies. Such criticism and focus on
the value of medicines has resulted in proposed policy and legislative
- More to follow, for following part double click ID:nRSH4027RsRecent news on AstraZeneca
See all newsREG - ConnectingExcellence - Appointment of Chief Performance & Growth Officer
AnnouncementREG - AstraZeneca PLC - Tozorakimab met OBERON/TITANIA primary endpoints
AnnouncementREG - AstraZeneca PLC - Notification of Admission of Shares
AnnouncementREG - AstraZeneca PLC - Imfinzi approved in EU for early gastric cancer
AnnouncementREG - AstraZeneca PLC - Notice of AGM
Announcement